CIBMTR Reporting Implementation Guide - Local Development build (v0.1.6). See the Directory of published versions
Active as of 2023-05-05 |
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:ValueSet ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "med-all-form2400-vs"] ; #
fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This value set includes codes based on the following rules:</p><ul><li>Import all the codes that are contained in <a href=\"ValueSet-med-addition-peri-transplant-vs.html\">RxNorm - Additional Drugs in Peri-Transplant Period</a></li><li>Import all the codes that are contained in <a href=\"ValueSet-med-gvhd-prophylaxis-vs.html\">RxNorm - GVHD Prophylaxis</a></li><li>Import all the codes that are contained in <a href=\"ValueSet-med-mobilizing-agents-vs.html\">RxNorm - Mobilizing Agents (auto only)</a></li><li>Import all the codes that are contained in <a href=\"ValueSet-med-post-hct-disease-therapy-planned-vs.html\">RxNorm - Post-HCT Disease Therapy Planned</a></li><li>Import all the codes that are contained in <a href=\"ValueSet-med-prep-regimen-vs.html\">RxNorm - Prep Regimen</a></li><li>Import all the codes that are contained in <a href=\"ValueSet-med-prior-exposure-vs.html\">RxNorm - Prior Exposure: Potential Study Eligibility</a></li></ul></div>"
] ; #
fhir:url [ fhir:v "http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-all-form2400-vs"^^xsd:anyURI] ; #
fhir:version [ fhir:v "0.1.6"] ; #
fhir:name [ fhir:v "RxNormAll2400VS"] ; #
fhir:title [ fhir:v "RxNorm - All of Form 2400"] ; #
fhir:status [ fhir:v "active"] ; #
fhir:experimental [ fhir:v "true"^^xsd:boolean] ; #
fhir:date [ fhir:v "2023-05-05T10:07:01-05:00"^^xsd:dateTime] ; #
fhir:publisher [ fhir:v "The Medical College of Wisconsin, Inc. and the National Marrow Donor Program"] ; #
fhir:contact ( [
fhir:name [ fhir:v "The Medical College of Wisconsin, Inc. and the National Marrow Donor Program" ] ;
( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "http://www.cibmtr.org" ] ] )
] [
fhir:name [ fhir:v "Bob Milius" ] ;
( fhir:telecom [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "bmilius@nmdp.org" ] ] )
] ) ; #
fhir:description [ fhir:v "RxNorm codes for all of Form 2400"] ; #
fhir:compose [
( fhir:include [
( fhir:valueSet [
fhir:v "http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-addition-peri-transplant-vs"^^xsd:anyURI ;
fhir:link <http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-addition-peri-transplant-vs> ] ) ] [
( fhir:valueSet [
fhir:v "http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-gvhd-prophylaxis-vs"^^xsd:anyURI ;
fhir:link <http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-gvhd-prophylaxis-vs> ] ) ] [
( fhir:valueSet [
fhir:v "http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-mobilizing-agents-vs"^^xsd:anyURI ;
fhir:link <http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-mobilizing-agents-vs> ] ) ] [
( fhir:valueSet [
fhir:v "http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-post-hct-disease-therapy-planned-vs"^^xsd:anyURI ;
fhir:link <http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-post-hct-disease-therapy-planned-vs> ] ) ] [
( fhir:valueSet [
fhir:v "http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-prep-regimen-vs"^^xsd:anyURI ;
fhir:link <http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-prep-regimen-vs> ] ) ] [
( fhir:valueSet [
fhir:v "http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-prior-exposure-vs"^^xsd:anyURI ;
fhir:link <http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-prior-exposure-vs> ] ) ] )
] . #
IG © 2020+ The Medical College of Wisconsin, Inc. and the National Marrow Donor Program
Package nmdp.fhir.cibmtr-reporting#0.1.6 based on FHIR 4.0.1. Generated 2023-05-05
Links: Table of Contents |
QA Report
HL7®, and FHIR® are the registered trademarks of Health Level Seven International
and their use of these trademarks does not constitute an endorsement by HL7.